XClose

UCL Population Health Sciences

Home
Menu

Cell, Gene and Novel Therapies MSc

Gain specialist knowledge of cutting-edge biological therapies for genetic and acquired diseases at University College London, the world's #9 university (QS World University Ranking 2025).

Learn from leading scientists and clinicians about gene delivery, stem cell manipulation, RNA-based technologies, personalised medicine and more. Covering applied genomics, molecular disease, clinical applications, this Master's degree also included training in research methods and statistics. 

Choose between two routes 

Cell and Molecular Therapies (CMT)

Learn the basics of genetic diseases, stem cell and tissue repair plus clinical applications of cell and gene therapy and gene editing technologies. 

Personalied Medicine (PM)

Explore novel therapies like RNA treatments, preclinical drug development, and clinical translation. Learn to apply genomic and multiomic data to personalised medicine. 

Register your interest >>


What this course will give you 

  • Study at one of the world's top ten universities. UCL is ranked 3rd in the world for public health (ShanghaiRankings 2024), 9th in the world as a university (QS World Rankings 2025) and is rated No.1 for research power and impact in medicine, health and life sciences (REF 2021).   
     
  • The programme is delivered by scientists and clinicians researching, developing and testing advanced treatments for genetically inherited and acquired diseases using gene delivery technology, stem cell manipulation, DNA repair techniques and novel RNA based technologies.
     
  • Development of advanced therapies is rapidly expanding and poses different challenges to traditional drug development, hence the need for a new workforce with appropriate training for this task. This programme offers access to the breadth of expertise and cutting-edge research in this area available within UCL Great Ormond Street Institute of Child Health (UCL GOS ICH), its clinical partner Great Ormond Street Hospital (GOSH), and UCL at large.  
     
  • This programme, taught by leading academics and clinicians in the field of cell, gene and novel therapies, prepares you to become a scientist or researcher in academia or industry, or join regulatory bodies, as well as for progression to a higher research degree.
     
  • UCL has the largest concentration of clinicians and researchers active in cell, gene and novel therapies research in Europe. This is reflected by the many groups conducting high-quality research and clinical trials in the field including researchers at UCL GOS ICH, the Division of Infection & Immunity, the Institute of Ophthalmology, the EGA Institute for Women's Health, the Institute of Genetics and the Cancer Institute. 
     
  •  Study at UCL GOS ICH, which together with GOSH, is the largest centre in Europe devoted to clinical, basic research and postgraduate education in children's health, including haematopoietic stem cell transplantation (HSCT), RNA therapy and gene and cell-based therapies. 

The foundation of your career

This programme aims to equip students for careers in research, education, medicine and business in academic, clinical, industrial and regulatory settings. Examples of potential careers could include: 

  • Academic research and/or lecturing in a university, research institution, or other higher education setting. 
     
  • Developing new therapies or intellectual property in National Healthcare systems and  pharmaceutical industry or other biomedicine related business venture. Conducting clinical trials as part of a team of clinicians, scientists and allied health professionals. Monitoring and analysing the results of clinical trials as part of a clinical trials unit.  

Graduates of the programme have gone on to leadership roles in the NHS and other healthcare organisations in the UK and overseas. Some of our graduates have moved into roles in industry in pharmaceutical companies or consulting organisations. Others have gone on to further study, taking on PhDs or fellowships while others have launched their own businesses. 

Our graduates have been employed by organisations such as Biologics, IQVIA, Clinigen, Datar Cancer Genetics, PPD Global Ltd., UK Biocentre and Fishawack Health, as well as universities in the UK and abroad. * 

*Graduate Outcomes survey carried out by the Higher Education Statistics Agency (HESA), looking at the destinations of UK and EU graduates in the 2017-18, 2018-19, 2019-20, 2020-21 cohorts. 


Programme leads


Contact us

This programme is recruiting for September 2025, for further information about modules, study mode, fees and how to apply, please contact our programme team by email cgt@ucl.ac.uk.


Register your interest

Do you want to receive updates from our faculty, along with invitations to upcoming open days, taster sessions and more? Complete the form below to register your interest in studying with us, selecting 'Child Health' as your subject of interest.

Gecko Form Widget Placeholder21FO00ics5m04b00gzq6u44yq6